公司公告汇总 浙江东日股份有限公司发布股票交易风险提示公告。截至2025年7月25日收盘，公司股价自2025年6月16 日以来累计涨幅为122.06%，可能存在炒作风险，敬请投资者注意二级市场交易风险。公司主营业务为 农副产品批发交易市场运营管理、生鲜食材配送业务和豆制品生产加工领域相关业务，日常经营不涉 及"脑机接口"业务。截至目前，公司参股公司培安美（浙江）科技股份有限公司未签署任何涉及"脑机 接口"业务相关的合作研发、设备采购、产品销售等书面实质性协议。截至2025年6月底，培安美公司本 年累计实现营业收入28.15万元，净利润-62.82万元，对公司经营业绩影响较小。根据证监会行业分类， 公司所属"租赁和商务服务业"，公司在中证指数有限公司查询的最新行业静态市盈率为29.83，公司当 前的最新市盈率为94.73，远高于行业指数相关指标。经公司自查，确认不存在应披露而未披露的重大 信息，日常经营活动正常，不存在影响公司股票交易价格异常波动的重大事项。公司指定的信息披露媒 体为《上海证券报》，指定的信息披露网站为上海证券交易所网站。有关本公司的信息请以公司在上述 媒体和网站发布的公告为准，敬请广大投资者理 ...

浙江东日股份有限公司 股票交易风险提示公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带责任。 股票代码： 600113 股票简称：浙江东日 公告编号：2025-042 重要内容提示： ●截至 2025 年 7 月 25 日收盘，公司股价自 2025 年 6 月 16 日以来累计涨幅 为 122.06%，股价剔除大盘和板块整体因素后的实际涨幅较大，可能存在炒作风 险，敬请投资者注意二级市场交易风险。 一、相关风险提示 （一）股价短期涨幅较大风险 截至 2025 年 7 月 25 日收盘，公司股价自 2025 年 6 月 16 日以来 累计涨幅为 122.06%，股价剔除大盘和板块整体因素后的实际涨幅较 大，可能存在炒作风险，敬请投资者注意二级市场交易风险，理性决 策、审慎投资。 （二）主营业务未发生变化 公司主营业务为农副产品批发交易市场运营管理（含市场交易管 理、市场租赁业务）、生鲜食材配送业务和豆制品生产加工领域的相 关业务。日常经营不涉及"脑机接口"业务。经自查，公司目前经营 情况正常，内、外部经营环境未发生重大变化 ...

Core Points - The company Zhejiang Dongri Co., Ltd. is holding a shareholders' meeting on July 28, 2025, to elect members for its tenth board of directors [1][5] - The meeting will include both on-site and online voting methods to ensure shareholder participation [1][2] - The company has proposed candidates for both non-independent and independent director positions, with terms lasting three years from the date of election [6][8] Meeting Procedures - Shareholders must present identification and relevant documents to attend the meeting [2] - Only registered shareholders and their authorized representatives can participate in the voting process [2][4] - The meeting will allow for a one-hour speaking period, with each shareholder limited to five minutes for their remarks [3][4] Election Proposals - The company has nominated Dong Boyu and Tu Feiyun as candidates for non-independent directors [6][7] - The independent director candidates include Che Lei, Zhu Xin, and Cheng Zhongming, with Che Lei and Cheng Zhongming being accounting professionals [8][9]

浙江东日股份有限公司 2025 年第三次临时股东会 会 议 材 料 浙江东日股份有限公司董事会 2025 年 7 月 28 日 目 录 | 1、会议议程----------------------------------------------3-4 | | --- | | 2、会议须知----------------------------------------------5-6 | | 3、议案1.00：关于选举董事的议案---------------------------7-8 | | 议案1.01：选举董伯俞先生为公司第十届董事会非独立董事 | | 议案1.02：选举涂飞云先生为公司第十届董事会非独立董事 | | 4、议案2.00：关于选举独立董事的议案---------------------9-10 | | 议案2.01：选举车磊先生为公司第十届董事会独立董事 | | 议案2.02：选举朱欣先生为公司第十届董事会独立董事 | | 议案2.03：选举程仲鸣先生为公司第十届董事会独立董事 | 2 浙江东日股份有限公司 2025 年第三次临时股东会议程 时间：2025 年 7 月 28 日下午 14 ...

Core Viewpoint - Zhejiang Dongri (600113.SH) has experienced a stock price surge of over 120% in less than a month due to speculation around the "brain-computer interface" concept, despite its core business being unrelated to this field [1][2][3]. Group 1: Stock Price Surge and Market Reaction - Zhejiang Dongri was placed under strict monitoring by the Shanghai Stock Exchange starting July 14 due to abnormal trading behavior, with its stock price significantly deviating from its fundamentals [1][2]. - The stock price increased by over 120% from June 16 to July 11, driven by market speculation following a public announcement regarding a partnership in brain-computer interface technology [1][2][3]. - Following a clarification that no formal agreement was made regarding the partnership, the stock experienced a sharp decline, indicating intense market speculation and volatility [3][6]. Group 2: Company Background and Financials - Zhejiang Dongri's main business includes the wholesale trading of agricultural products, fresh food distribution, and tofu production, with a reported revenue of 723 million RMB in 2024, down 18.44% year-on-year [5][6]. - The subsidiary involved in the brain-computer interface concept, Peianmei, was established in September 2024 and has reported minimal revenue of 2.87 million RMB with a net loss of 661,400 RMB as of May 2025 [5][6]. - Peianmei's business scope changed from special medical food sales to smart robotics and software development, reflecting a significant shift in focus within a year of its establishment [5][6]. Group 3: Market Dynamics and Investor Behavior - The stock price surge was largely driven by retail investors, with over 2.5 billion RMB in trading volume and a net buying of 66.11 million RMB during the speculative period [3][6]. - The influx of leveraged funds contributed to the stock price increase, with the financing balance rising from 565 million RMB to 945 million RMB, accounting for 7.41% of the stock's market value [3][6]. - As of July 14, Zhejiang Dongri's dynamic price-to-earnings ratio reached 88, significantly higher than the industry average of 28, indicating a severe disconnect between market valuation and fundamental performance [6].

Core Viewpoint - Zhejiang Dongri has experienced a dramatic stock price increase of over 120% within a month, driven by speculation around the "brain-computer interface" concept, despite its core business being unrelated to this technology [1][2]. Group 1: Stock Performance and Market Reaction - From June 16 to July 11, Zhejiang Dongri's stock price surged over 120%, leading to its inclusion in the Shanghai Stock Exchange's list of key monitored securities starting July 14 [1][2]. - The stock price increase was largely influenced by a message from its subsidiary, Peianmei, regarding a potential collaboration with Capital Medical University on brain-computer interface technology [2]. - Following the announcement, Zhejiang Dongri's stock hit multiple trading limits, with five consecutive days of trading halts, reflecting intense market speculation [2][3]. Group 2: Company Background and Financials - Zhejiang Dongri primarily operates in the agricultural products wholesale market, fresh food delivery, and tofu production, with a reported revenue of 7.23 billion RMB in 2024, down 18.44% year-on-year [4][5]. - The subsidiary Peianmei, established in September 2024, initially focused on special medical food but later shifted its business scope to include smart robotics and software development [5]. - As of May 2025, Peianmei reported a revenue of only 2.87 million RMB, with a net loss of 661,400 RMB, raising concerns about the sustainability of its business model [5]. Group 3: Investor Behavior and Market Dynamics - Retail investors showed high participation in Zhejiang Dongri's stock, with over 2.5 billion RMB in trading volume during the price surge, indicating a trend of speculative trading [3]. - Institutional investors also contributed to the buying trend, with a net purchase of 218 million RMB during the same period [3]. - The company's financing balance increased significantly from 565 million RMB to 945 million RMB, accounting for 7.41% of its market capitalization, further fueling the stock price rise [3].

Group 1 - The stock price of Zhejiang Dongri (600113) closed at 30.99 yuan on July 11, 2025, down 2.18%, with a turnover rate of 3.48% and a trading volume of 143,400 shares, amounting to a total transaction value of 443 million yuan [1] - On July 11, 2025, the net inflow of main funds into Zhejiang Dongri was 48.32 million yuan, accounting for 10.91% of the total transaction value, while retail investors had a net outflow of 59.14 million yuan, representing 13.36% of the total transaction value [2][4] - Zhejiang Dongri issued a stock trading risk warning, indicating that its stock price had increased by 121.99% since June 16, 2025, which may indicate speculative risks [2][4] Group 2 - The company primarily operates in the wholesale trading market for agricultural products, fresh food distribution, and soybean product processing, and does not engage in "brain-computer interface" business [2] - As of the end of May 2025, the company's associate, Peianmei (Zhejiang) Technology Co., Ltd., reported a cumulative revenue of 28,700 yuan and a net loss of 661,400 yuan, which has a minimal impact on the company's operating performance [2] - The current price-to-earnings ratio of Zhejiang Dongri is 99.05, significantly higher than the industry average static P/E ratio of 28.19 [2]

股票代码： 600113 股票简称：浙江东日 公告编号：2025-041 浙江东日股份有限公司 股票交易风险提示公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带责任。 重要内容提示： ●截至 2025 年 7 月 11 日收盘，公司股价自 2025 年 6 月 16 日以来累计涨幅 为 121.99%，股价剔除大盘和板块整体因素后的实际涨幅较大，可能存在炒作风 险，敬请投资者注意二级市场交易风险。 ●公司主营业务为农副产品批发交易市场运营管理（含市场交易管理、市场 租赁业务）、生鲜食材配送业务和豆制品生产加工领域的相关业务。日常经营不 涉及"脑机接口"业务。 截至目前，公司参股公司培安美（浙江）科技股份有限公司未签署任何涉及 "脑机接口"业务相关的合作研发、设备采购、产品销售等书面实质性协议。截 至 2025 年 5 月底，培安美公司本年累计实现营业收入 2.87 万元，净利润-66.14 万元，对公司经营业绩影响较小。 ●根据证监会行业分类，公司所属"租赁和商务服务业"，公司在中证指数 有限公司查询的最新（数据统计至 ...

New Stock Offerings - Ji Chuan Pharmaceutical (600566) is in the offer period from June 18, 2025, to July 17, 2025[1] - Zhong Cheng Tui (300208) has 5 trading days remaining until the last trading day[1] - Tui Shi Jin Gang (600190) also has 5 trading days remaining until the last trading day[1] Delisting and Trading Alerts - Hengli Tui (000622) has 2 trading days remaining until the last trading day[1] - Tui Shi Jiu You (600462) has only 1 trading day remaining until the last trading day[1] - ST Zi Tian (300280) has an announcement dated July 10, 2025, regarding trading status[1] Abnormal Fluctuations - Changcheng Military Industry (601606) reported severe abnormal fluctuations on July 2, 2025[1] - An abnormal fluctuation was noted for Wei Xin Kang (603676) on July 5, 2025[2] - Multiple stocks, including ST Wei Ming (002581), reported abnormal fluctuations on July 11, 2025[2]

Group 1: Market Overview - US stock markets rose, with the Dow Jones up 0.43%, Nasdaq up 0.09%, and S&P 500 up 0.27%. Notable stock movements included Tesla rising 4.73% and Nvidia up 0.75% [1] - The Shanghai Composite Index reached a new high, boosting market confidence and potentially attracting more capital into the market, with expectations of a continued upward trend [3] Group 2: Industry Insights - The ice-making industry in Henan is experiencing a surge in demand due to high temperatures, with some factories producing nearly 300 tons of ice daily, leading to a doubling of sales. The market for ice products is projected to exceed 63 billion yuan by 2026 [4] - Coal futures saw a significant increase, with coking coal rising 3.98% and coking coal up 3.44%. The demand for coal is expected to rise due to seasonal factors and policy changes aimed at reducing excess production capacity [5] - JD.com is entering the short drama market, indicating a strategic focus on this growing sector, with competitive salaries offered to attract top talent [5][6] - The micro-short drama market in China is projected to reach 505 billion yuan by 2024, surpassing annual box office revenues for films, with a compound annual growth rate of 19.2% expected [6] Group 3: Company Announcements - Baosteel plans to adjust the price of rare earth concentrate for Q3 2025 to 19,109 yuan per ton [9] - Guosheng Financial Holdings expects a net profit of 150 million to 220 million yuan for the first half of the year, a year-on-year increase of 236.85% to 394.05% [9] - The expected net profit for Sailyus in the first half of the year is between 2.7 billion to 3.2 billion yuan, reflecting a significant year-on-year increase of 66.20% to 96.98% [9] - WuXi AppTec anticipates an adjusted net profit of approximately 6.315 billion yuan for the first half of the year, a year-on-year increase of about 44.43% [9] Group 4: Emerging Technologies - Chengdu Hanhai Fusion Energy is set to witness a milestone event on July 18, marking the completion of China's first linear fusion device, HHMAX-901, which signifies a major breakthrough in the commercialization of controlled nuclear fusion [8]